Clinical Results with Catheter Ablation: AV Junction, Atrial Fibrillation and Ventricular Tachycardia

Jonathan Weinstock, Paul J. Wang, Munther K. Homoud, Mark S. Link, N. A.Mark Estes

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

With the limitations of pharmacologic and device therapies for atrial fibrillation and ventricular tachycardia, catheter ablation is assuming a larger role in the management of patients with these common arrhythmias. Multiple case series and clinical trials have helped to define the evolving role of these techniques for ablation of the atrioventricular node, atrial fibrillation, and ischemic ventricular tachycardia. Based on very low complication rates, excellent efficacy and proven outcomes with radiofrequency ablation of the atrioventricular node, this approach with permanent pacing should play a larger role in the treatment of symptomatic patients with permanent atrial fibrillation. While linear ablation of atrial fibrillation has limited clinical utility for the treatment of this common arrhythmia, the results of multiple case series of focal atrial fibrillation ablation indicate the potential for an expanding role of this curative technique. Catheter ablation techniques for ventricular tachycardia in the setting of coronary artery disease have a role as supplemental therapy to the implantable cardioverter defibrillator in patients with recurrent pharmacologically refractory ventricular arrhythmias requiring frequent device interventions.

Original languageEnglish (US)
Pages (from-to)275-288
Number of pages14
JournalJournal of Interventional Cardiac Electrophysiology
Volume9
Issue number2
DOIs
StatePublished - Oct 1 2003

Fingerprint

Catheter Ablation
Ventricular Tachycardia
Atrial Fibrillation
Ablation Techniques
Cardiac Arrhythmias
Atrioventricular Node
Equipment and Supplies
Implantable Defibrillators
Therapeutics
Coronary Artery Disease
Clinical Trials

Keywords

  • Arrhythmia
  • Atrial fibrillation
  • Atrioventricular junction
  • Catheter ablation
  • Clinical trials
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Clinical Results with Catheter Ablation : AV Junction, Atrial Fibrillation and Ventricular Tachycardia. / Weinstock, Jonathan; Wang, Paul J.; Homoud, Munther K.; Link, Mark S.; Estes, N. A.Mark.

In: Journal of Interventional Cardiac Electrophysiology, Vol. 9, No. 2, 01.10.2003, p. 275-288.

Research output: Contribution to journalArticle

Weinstock, Jonathan ; Wang, Paul J. ; Homoud, Munther K. ; Link, Mark S. ; Estes, N. A.Mark. / Clinical Results with Catheter Ablation : AV Junction, Atrial Fibrillation and Ventricular Tachycardia. In: Journal of Interventional Cardiac Electrophysiology. 2003 ; Vol. 9, No. 2. pp. 275-288.
@article{32a2bc86640e47c1a82efd0c3e27bcae,
title = "Clinical Results with Catheter Ablation: AV Junction, Atrial Fibrillation and Ventricular Tachycardia",
abstract = "With the limitations of pharmacologic and device therapies for atrial fibrillation and ventricular tachycardia, catheter ablation is assuming a larger role in the management of patients with these common arrhythmias. Multiple case series and clinical trials have helped to define the evolving role of these techniques for ablation of the atrioventricular node, atrial fibrillation, and ischemic ventricular tachycardia. Based on very low complication rates, excellent efficacy and proven outcomes with radiofrequency ablation of the atrioventricular node, this approach with permanent pacing should play a larger role in the treatment of symptomatic patients with permanent atrial fibrillation. While linear ablation of atrial fibrillation has limited clinical utility for the treatment of this common arrhythmia, the results of multiple case series of focal atrial fibrillation ablation indicate the potential for an expanding role of this curative technique. Catheter ablation techniques for ventricular tachycardia in the setting of coronary artery disease have a role as supplemental therapy to the implantable cardioverter defibrillator in patients with recurrent pharmacologically refractory ventricular arrhythmias requiring frequent device interventions.",
keywords = "Arrhythmia, Atrial fibrillation, Atrioventricular junction, Catheter ablation, Clinical trials, Ventricular tachycardia",
author = "Jonathan Weinstock and Wang, {Paul J.} and Homoud, {Munther K.} and Link, {Mark S.} and Estes, {N. A.Mark}",
year = "2003",
month = "10",
day = "1",
doi = "10.1023/A:1026205028816",
language = "English (US)",
volume = "9",
pages = "275--288",
journal = "Journal of Interventional Cardiac Electrophysiology",
issn = "1383-875X",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Clinical Results with Catheter Ablation

T2 - AV Junction, Atrial Fibrillation and Ventricular Tachycardia

AU - Weinstock, Jonathan

AU - Wang, Paul J.

AU - Homoud, Munther K.

AU - Link, Mark S.

AU - Estes, N. A.Mark

PY - 2003/10/1

Y1 - 2003/10/1

N2 - With the limitations of pharmacologic and device therapies for atrial fibrillation and ventricular tachycardia, catheter ablation is assuming a larger role in the management of patients with these common arrhythmias. Multiple case series and clinical trials have helped to define the evolving role of these techniques for ablation of the atrioventricular node, atrial fibrillation, and ischemic ventricular tachycardia. Based on very low complication rates, excellent efficacy and proven outcomes with radiofrequency ablation of the atrioventricular node, this approach with permanent pacing should play a larger role in the treatment of symptomatic patients with permanent atrial fibrillation. While linear ablation of atrial fibrillation has limited clinical utility for the treatment of this common arrhythmia, the results of multiple case series of focal atrial fibrillation ablation indicate the potential for an expanding role of this curative technique. Catheter ablation techniques for ventricular tachycardia in the setting of coronary artery disease have a role as supplemental therapy to the implantable cardioverter defibrillator in patients with recurrent pharmacologically refractory ventricular arrhythmias requiring frequent device interventions.

AB - With the limitations of pharmacologic and device therapies for atrial fibrillation and ventricular tachycardia, catheter ablation is assuming a larger role in the management of patients with these common arrhythmias. Multiple case series and clinical trials have helped to define the evolving role of these techniques for ablation of the atrioventricular node, atrial fibrillation, and ischemic ventricular tachycardia. Based on very low complication rates, excellent efficacy and proven outcomes with radiofrequency ablation of the atrioventricular node, this approach with permanent pacing should play a larger role in the treatment of symptomatic patients with permanent atrial fibrillation. While linear ablation of atrial fibrillation has limited clinical utility for the treatment of this common arrhythmia, the results of multiple case series of focal atrial fibrillation ablation indicate the potential for an expanding role of this curative technique. Catheter ablation techniques for ventricular tachycardia in the setting of coronary artery disease have a role as supplemental therapy to the implantable cardioverter defibrillator in patients with recurrent pharmacologically refractory ventricular arrhythmias requiring frequent device interventions.

KW - Arrhythmia

KW - Atrial fibrillation

KW - Atrioventricular junction

KW - Catheter ablation

KW - Clinical trials

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=0242596483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242596483&partnerID=8YFLogxK

U2 - 10.1023/A:1026205028816

DO - 10.1023/A:1026205028816

M3 - Article

C2 - 14574041

AN - SCOPUS:0242596483

VL - 9

SP - 275

EP - 288

JO - Journal of Interventional Cardiac Electrophysiology

JF - Journal of Interventional Cardiac Electrophysiology

SN - 1383-875X

IS - 2

ER -